Microbot Medical expands LIBERTY Robotic System commercial rollout

The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026

Experts convene in India to push for urgent action on dengue treatment gaps

Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches

ECI taps industry veteran Khalid Raja to drive strategic growth

Move comes amid rising regulatory pressures

Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment

Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines

Microbot Medical begins full US market release of LIBERTY endovascular robotic system

Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology

Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners

The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure

Zealand Pharma launches major US research hub in Cambridge, Massachusetts

The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities

Somerset smashes fund target, raises $288M to power India’s healthcare transformation

Rapid medical weight loss fuels surge in facial aesthetics, Allergan data shows

Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality